INTRODUCTION
Hydrogels, defined as hydrophilic polymers which are able to contain a considerable amount of water without dissolving, form an important class of polymeric materials which can be used as drug delivery systems. Since portant feature. Investigations with controlledrelease hydrogel preparations with a relatively short period of drug release are scarce. Very few studies have been published in which nondisintegrating hydrogel matrices were designed to be administered by the oral or rectal route [ 4-71. A hydrogel-procainamide preparation has been given orally to rabbits, which resulted in a prolonged release profile compared to a conventional capsule. Morphineloaded poly( ethyleneglycol)-base hydrogels administered rectally to four patients exhibited near constant and prolonged drug delivery, but in uiuo release was found to be slower than in vitro. The rectal route is very suitable for drug administration [B] , and in previous studies a rate-controlled osmotic drug delivery system was successfully applied in healthy subjects [ 9-121. In contrast to data in viva the in vitro release characteristics of drugs and solutes from hydrogels of HEMA and ethylene glycol dimethacrylate (EGDMA) as crosslinking agent have been described extensively [13-151. In the present study in uiuo investigations with hydrogels of the HEMA and EGDMA type containing antipyrine or theophylline as active substance are described. Their plasma and saliva level profiles were studied after rectal administration in healthy volunteers. Hydrogel drug preparations can be made by mixing the drug with the monomer mixture followed by polymerization, or by impregnating the hydrogel with drug solutions. With the latter soaking technique possible residual monomers or initiator can be removed from the system before drug loading [6, 13, 161 and therefore this method is to be preferred for the preparation of drug delivery systems.
Hydrogels were made with antipyrine as a model compound since it is highly watersoluble and well absorbed rectally, while plasma sampling can be replaced by saliva sampling [ 91. Theophylline was used (as the water-soluble choline salt) since it is frequently applied rectally in actual practice and has a relatively low therapeutic index [B, lo] . With conventional oral and rectal dosage forms and even with some of the sustainedrelease or retard formulations an optimal and in uiuo predictable plasma concentration-time profile is not achieved. A relatively constant rate of drug input would be most desirable in theophylline prophylactic therapy. 
MATERIALS AND METHODS

Materials
In vitro release experiments
The in vitro release experiments were performed in a glass flask equipped with a magnetic stirrer in 100 ml isotonic solution (5.5% glucose) at 37.0 f 02°C. Since the model drugs are highly water-soluble, sink conditions were always maintained. At regular time intervals samples were taken and replaced by the same volume of glucose solution; drug concentrations were determined spectrophotometrically (Perkin Elmer DB 124).
Subjects and drug administration
Eight healthy male volunteers, age 22-34, weight 60-78 kg, participated after medical examination.
All had given informed consent. Two of them participated in the antipyrine study and six in the study with theophylline. The latter study was approved by the Committee for Medical Ethics of the University Hospital and the faculty of Medicine, University of Leiden.
In the antipyrine study one hydrogel drug preparation was kept in the rectum for 72 h. Drug administration started at 9 a.m.; saliva samples were collected at regular time intervals during 96 h. When the subjects had to empty their bowels during the 72 h of drug administration, the hydrogel was recovered, cleaned and inserted again.
Rectal drug administration of the theophylline-containing hydrogel preparation took place during 24 h. Drug administration started at 9 a.m. and after 12 h the system was removed and replaced by a second one, which was kept in the rectum for another 12 h. Blood samples were taken just before rectal application and after 0. 25, 0.5, 0.75, 1, 1.5, 2,3,4,6,8,10, 12,15, 19,22,24,28, 31 , 34 and 37 h from a cannula in a forearm vein. Plasma samples were obtained by centrifuging the heparinized blood samples immediately after blood sampling.
Saliva samples were collected at regular time intervals in the period from 14 to 40 h when blood sampling was less frequent.
Plasma and saliva samples were stored at -20°C until assayed. The hydrogels were administered, if possible, after defecation.
When the subjects had a bowel movement during the 24 h of drug administration the same procedure was followed as described above. The intake of caffeine was prohibited from 24 h before drug administration onwards until the last sample had been collected.
Assay of antipyrine and theophylline in saliva and plasma
The antipyrine and theophylline concentrations were determined according to previously described methods [9, lo] , except that with the assay of theophylline, antipyrine was used as an internal standard and the chromatographic conditions were modified: a radialpak C 8 reverse phase column with an eluent of 0.03 M acetate buffer (pH 4.0) with 4% tetrahydrofuran.
Linear calibration curves were obtained from 0.2 to 10 pg theophylline/ml saliva or plasma.
Calculations and pharmacokinetic analysis
The total dose administered rectally was calculated from the difference between the amount in the hydrogel before application and the amount remaining after application. The latter amount was determined by in vitro release afterwards until no further increase in the drug concentration could be found. The total area under the plasma or saliva concentration-time curves (AUC) was calculated according to a method described by Chiou [ 171. The clearance values were determined by dividing the total dose administered by AUC. The elmination rate constant (k,l) was obtained by regression analysis of the logarithm of plasma or saliva concentration against time after withdrawal of the hydrogel. Elimination half-lives (tl,+l) were calculated as ts,l = 0.693/k,l.
Each time a sample was taken the cumulative amount released in vivo was determined by means of a deconvolution procedure (point area method) which calculated the actual input by relating the input to a unit impulse response function [18] . For each individual this function was calculated from the k,, and the clearance as determined at the end of the rectal experiment.
RESULTS
The in vitro release of antipyrine and theophylline from hydrogel preparations I and II were measured under stirred and non-stirred conditions.
There were no significant differences between continuous stirring and stirring for 10 s once every hour just before sample taking. The very reproducible drug release from preparation I in isotonic glucose was in agreement with a matrix-type profile and after 72 h 82 t 2% (1.12 g; n = 3) of the total amount of antipyrine was present in the dis- solution medium. The in vitro drug release from preparation II containing theophylline is shown in Fig. 1 . In 12 h the hydrogel released 144 + 3 mg (calculated as theophylline) which was 80% of the total amount in the dosage form, Figure 2 shows the saliva concentrationtime curves of antipyrine after rectal administration of the hydrogel preparation to the two subjects. The administered dose was 1.13 and 1.09 g antipyrine for subjects I and II, respectively; the AUC, clearance and k,l were 0.52 and 0.44 g h/l, 2.2 and 2.5 l/h, and 0.065 and 0.047 h-l respectively. Figure 3 shows the cumulative amount of antipyrine released in uiuo, as calculated with the deconvolution method, together with the release profile in vitro (solid line). A very good agreement of the antipyrine release in uiuo with that in vitro is obtained. With this drug delivery system the amount and rate of release of antipyrine after rectal application in man seems to be quite predictable on the basis of in vitro experiments.
The theophylline concentration-time curves in plasma and saliva after rectal administration of the hydrogels to subject B and 
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C are given in Fig. 4 . A rapid increase in plasma concentration was found for the first 4 to 5 h and from then onwards the concentration remained almost constant until the hydrogel preparation was replaced by a second one. Again the plasma concentrations rose relatively rapidly for 4 to 5 h and then remained nearly constant until the dosage form was removed. During the period of almost constant theophylline concentrations and during the elimination phase the saliva plasma concentration ratio was reasonably constant. The plasma concentration-time curves were quite similar in all six subjects; in Fig. 5 are given together with the calculated clearance values. The mean elimination halflife was 5.1 h and the mean clearance value 3.7 l/h. The mean dose administered rectally with the hydrogel preparations during 24 h was 288 + 11 mg, which corresponds perfectly with the in vitro results. Figure 6 shows the cumulative in uiuo release of theophylline, calculated according to the deconvolution method, in all six subjects together with the mean in vitro release profile (solid line). In all cases the profile in uiuo showed an almost perfect agreement with the situation found in vitro in isotonic glucose.
The hydrogels with theophylline or antipyrine were well tolerated by all subjects and no complaints of inconvenience or irritation were reported. 
DISCUSSION
The results of the present study clearly indicate that it is quite possible to obtain a reproducible and predictable in uiuo drug release profile with a hydrogel drug delivery system. Since the release characteristics can be varied quite easily by for instance the geometry, the diameter, the crosslinking agent, the amount of crosslinker and the water content [6, 14, 19, 201 , hydrogels offer interesting perspectives for rate-controlled rectal delivery of several drugs.
With the hydrogel preparation containing theophylline, with a relatively high drug load and crosslinker percentage, an almost constant release was obtained for some time, leading to quite constant plasma concentration levels. However, the drug release profile from the hydrogels is of a matrix type, which means that the release rate decreases continuously. In principle there are possibilities to get a zero-order rate of release from hydrogels when drugs with short elimination half-lives other than our model drugs, are used. Lee et al. [ 211 introduced rate-controlling barriers by soaking the hydrogel outer layer with crosslinker followed by -iradiation. A zeroorder release of progesterone in vitro was demonstrated.
Also a change in geometry to cylinder-type sections or to hemispheric matrices coated with an impermeable layer except for an exposed cavity in the centre face, can be used to achieve nearly zero-order release kinetics in vitro [ 19, 221 . Using swelling systems a flattening of the release rate versus time profile can be obtained [7] .
In the present investigation the hydrogels were loaded with drugs by means of a soaking technique, which is rather time-consuming. This procedure was chosen in order to be able to wash the hydrogels after polymerization to ensure that no monomers or initiator were present in the final preparations [6, 13, 161 . When the drug is dissolved in the monomer mixture before polymerization, the hydrogels cannot be washed without loss of drug. Whether the impregnation or soaking technique could be further improved or accelerated remains the subject of further studies.
The antipyrine and theophylline elimination half-lives and clearance values obtained after application of the rectal drug delivery systems were comparable to previously obtained data [9, lo] 
